Sanofi (SAN.PA)
Paris - Paris Delayed price. Currency in EUR
Add to watchlist
As of 11:19AM CEST. Market open.
| Previous close | 93.08 |
| Open | 93.99 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 91.45 - 94.03 |
| 52-week range | 80.60 - 104.32 |
| Volume | |
| Avg. volume | 1,384,522 |
| Market cap | 114.25B |
| Beta (5Y monthly) | 0.45 |
| PE ratio (TTM) | 25.35 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.76 (4.04%) |
| Ex-dividend date | 13 May 2024 |
| 1y target est | N/A |
- Insider Monkey
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript
Sanofi (NASDAQ:SNY) Q1 2024 Earnings Call Transcript April 25, 2024 Sanofi reports earnings inline with expectations. Reported EPS is $0.96 EPS, expectations were $0.96. Sanofi isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Paul Hudson: Welcome to the Q1 2024 conference […]
- Zacks
Pharma Stock Roundup: MRK, SNY, AZN, NVS' Q1 Results, Pipeline & Regulatory Updates
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
- Investor's Business Daily
AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
AstraZeneca stock bolted higher Thursday — and is now within striking distance of a breakout — after its cancer drugs propelled a sales beat.
© 2024 Yahoo. All rights reserved.